Delivery Order SPE2DB25D3020-SPE2DB25FWKRR
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Estradiol 0.01% cream in 42.5 gram units, with a ceiling value of $3,720.99 and an ultimate completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,072.08 to AmerisourceBergen Drug Corp for the supply of Estradiol 0.01% cream in 42.5-gram quantities. This firm fixed-price delivery order, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- The Defense Logistics Agency awarded a $1,315.62 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Estradiol 0.01% Cream in 42.5 gram units. This non-set-aside contract represents a single delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The point of performance is located at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $2,676.81 delivery order to AmerisourceBergen Drug Corp for 42.5 grams of Estradiol 0.01% cream on September 2, 2025, with an ultimate completion date of September 3, 2025. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,864.28 to AmerisourceBergen Drug Corp for the supply of Estradiol 0.01% cream in 42.5-gram quantities. This firm fixed-price contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreements with the agency. The award utilized no set-aside designation, indicating competitive selection among...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Estradiol 0.01% Cream (42.5GM) on September 19, 2025, with a ceiling value of $1,114.92 and an ultimate completion date of September 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Estradiol 0.01% Cream in 42.5 gram quantities. This firm fixed-price delivery order, valued at $1,255.56, represents a non-competitive set-aside transaction and is scheduled for completion by August 26, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Estrace 0.01% Cream in 42.5-gram units, with a ceiling value of $2,357.79 and an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,817.31 for Estradiol 0.01% Cream (42.5 grams) on May 2, 2025, with completion scheduled for May 5, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Estrace 0.01% Cream in 42.5-gram quantities, with a ceiling value of $1,045.59. This is a firm fixed-price, non-set-aside contract with a completion date of September 16, 2025, and performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWKRRDelivery Order
The Defense Logistics Agency awarded a $6,211.59 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Estradiol 0.01% cream in 42.5-gram units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 18, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company holds substantial capacity to supply a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers. This delivery order for hormone replacement therapy medication reflects the company's ongoing role as a critical vendor within the DLA Medical Supply Chain, delivering both brand-name and generic medications to support federal health programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 9/17/25 |